Chief Executive Officer
Fri, Mar 1, 2024
Mar 1
41,704 shares @ $62.96
Decreased holdings by -7.80%
Net across this filing: 0.00% (+0 shares)
9th largest trade (out of 180)
Tax Sell-to-CoverAbnormally LargeLarge Trade
Trade made by an officer
Automatic sale to cover taxes on a vest — not a discretionary trade
Net holdings across this filing: +0.0% (+0 shares)
53% win rate · +15.5% median edge vs SPY (15 trades, 90-day · small sample)
Abnormally large trade for this company
Price 10% above 200-day moving average
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
APLSApellis Pharmaceuticals, Inc.
HealthcareBiotechnology